Patient-Centered Outcomes Research Institute (PCORI) is currently accepting applications for its Phased Large Grants for High-Impact Comparative Effectiveness Research 2026. Interested applicants are encouraged to click here to learn more about this opportunity and apply for it.
About (PCORI Phased Large Grants for High-Impact Comparative Effectiveness Research
The Patient-Centered Outcomes Research Institute (PCORI) offers funding for large-scale patient-centered comparative effectiveness research (CER) studies. The program aims to produce high-quality, actionable evidence to guide healthcare decision-making and improve care delivery in the United States.
Benefits of (PCORI Phased Large Grants for High-Impact Comparative Effectiveness Research
- Investigators may request up to $2 million in direct costs for a feasibility phase (up to 18 months in duration), with up to $20 million in direct costs for continuation to a full-scale phase (up to five years in duration).
(PCORI Phased Large Grants for High-Impact Comparative Effectiveness Research Requirements
Eligible organizations include:
- Academic research institutions
- Private sector research organizations
- Nonprofit and for-profit research entities
- U.S. federal agencies
- Foreign organizations demonstrating relevance and benefit to U.S. healthcare and patient-centered outcomes
Application Date and Process
- Click on the link to the application website to apply.
Application Deadline
01 September, 2026
Opportunity Application
View details of
(PCORI Phased Large Grants for High-Impact Comparative Effectiveness Research
Apply for (PCORI Phased Large Grants for High-Impact Comparative Effectiveness Research
🔍
